SRCH

 
Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • #100 - 2360 West Horizon Ridge Pkwy
  • Suite #100
  • Henderson, NV 89052

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001084226
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 1000 - Metal Mining
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Martin B. Oring CEO, Other
Company Directors
Martin B. Oring Chairman
Jordan Estra
John E. Mack
Company Notes
  • Formerly=Phage Genomics, Inc. until 6-05
  • Formerly=Regma Bio Technologies Limited until 2-04
  • Formerly=L.C.M. Equity, Inc. until 2-02
Service Providers
Accounting/Auditing Firm
Hein & Associates LLP
1999 Broadway Ste 4000
Denver, CO, 80202
United States

Legal Counsel
Baker & Hostetler LLP
45 Rockefeller Plaza
New York, NY, 10111-0100
United States

Investor Relations Firm
Not Available
SRCH Security Details
Share Structure
Market Value1 $15,500,161 a/o Sep 22, 2017
Authorized Shares 400,000,000 a/o Dec 31, 2016
Outstanding Shares 345,600,029 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 97,319,587 a/o Dec 31, 2016
Par Value 0.001
Transfer Agent(s)
Empire Stock Transfer Inc.
Shareholders
Shareholders of Record 172 a/o Dec 31, 2016
Short Selling Data
Short Interest 400 (0%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security